Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 6

    Surgical Traders and Manufacturers oppose classification of popular devices as Drugs, write to Health Minister

    Surgical Traders and Manufacturers oppose classification of popular devices as Drugs, write to Health Minister

    Farhat Nasim29 Nov 2019 12:31 PM IST
    New Delhi: The recent decision of the government to classify 4 common healthcare devices namely nebulizer, blood pressure, digital thermometer,...
    Cadilla Challenges NPPA order clauses on Price Fixation of 847 formulations, DOP rejects plea

    Cadilla Challenges NPPA order clauses on Price Fixation of 847 formulations, DOP rejects plea

    Farhat Nasim27 Nov 2019 2:22 PM IST
    The footnote (b) stated, "In respect of any other scheduled formulation, for which ceiling price is not mentioned above, the manufacturers shall...
    CDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard Quality

    CDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard Quality

    Farhat Nasim25 Nov 2019 3:41 PM IST
    New Delhi: The nodal drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared batches of 36 drugs as not of standard...
    NPPA fixes ceiling price of Zydus Cadila Tiotropium post DoP orders

    NPPA fixes ceiling price of Zydus Cadila Tiotropium post DoP orders

    Farhat Nasim24 Nov 2019 3:00 PM IST
    New Delhi: In an implementation of directions given in line with review orders issued by the Department of Pharmaceuticals (DOP), the apex drug price...
    Pharma Research being promoted by ICMR, others; Minister apprises parliament of initiatives

    Pharma Research being promoted by ICMR, others; Minister apprises parliament of initiatives

    Medical Dialogues Bureau23 Nov 2019 3:11 PM IST
    Minister of Health and Family Welfare, Ashwini Kumar Choubey while responding to the same stated that research in the field of pharmaceutical science,...
    With questions about safety of Merils Made in India BVS stent, NPPA defers its appeal for price exemption

    With questions about safety of Meril's Made in India BVS stent, NPPA defers its appeal for price exemption

    Medical Dialogues Bureau21 Nov 2019 12:09 PM IST
    New Delhi: With an industry association raising health and safety concerns about the flagship Sirolimus-Eluting BioResorbable vascular scaffold system...
    Govt still mulling to bring medical devices under CDSCO: Minister tells parliament

    Govt still mulling to bring medical devices under CDSCO: Minister tells parliament

    Farhat Nasim20 Nov 2019 2:36 PM IST
    New Delhi: The NITI Aayog has not rejected the proposal to bring medical devices under the Central Drugs Standard Control Organisation (CDSCO), the...
    USFDA lens slow down Indian pharma exports, says CII official

    USFDA lens slow down Indian pharma exports, says CII official

    Medical Dialogues Bureau19 Nov 2019 12:44 PM IST
    Hyderabad: Frequent inspections of Indian plants by the US FDA and subsequent observations slow down the growth of pharma exports even as US-China...
    NPPA fixes retail price of 12 combo drugs including Aspirin, Atorvastatin, Metformin; Details

    NPPA fixes retail price of 12 combo drugs including Aspirin, Atorvastatin, Metformin; Details

    Farhat Nasim17 Nov 2019 1:08 PM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    Medical Dialogues Bureau15 Nov 2019 4:29 PM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    NPPA Relief: Sun Pharma anti-cancer drug Gemcitabine gets price control exemption

    NPPA Relief: Sun Pharma anti-cancer drug Gemcitabine gets price control exemption

    Medical Dialogues Bureau14 Nov 2019 11:30 AM IST
    New Delhi: Through a recent order, the apex drug price regulator, National Pharmaceutical Pricing Authority (NPPA) has exempted drugmaker, Sun...
    NPPA fixes retail price of 14 drug formulations; Details

    NPPA fixes retail price of 14 drug formulations; Details

    Farhat Nasim13 Nov 2019 11:23 AM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok